Omega-3 polyunsaturated fatty acids (n-3 PUFAs) promote functional recovery in rats undergoing spinal cord injury (SCI). However, the precise molecular mechanism coupling n-3 PUFAs to neurorestorative responses is not well understood. The aim of the present study was to determine the spatiotemporal expression of fatty acid binding protein 5 (FABP5) after contusive SCI and to investigate whether this protein plays a role in n-3 PUFA–mediated functional recovery post-SCI. We found that SCI resulted in a robust spinal cord up-regulation in FABP5 mRNA levels (556 ± 187%) and protein expression (518 ± 195%), when compared to sham-operated rats, at 7 days post-injury (dpi). This upregulation coincided with significant alterations in the metabolism of fatty acids in the injured spinal cord, as revealed by metabolomics-based lipid analyses. In particular, we found increased levels of the n-3 series PUFAs, particularly docosahexaenoic acid (DHA; 22:6 n-3) and eicosapentaenoic acid (EPA; 20:5 n-3) at 7 dpi. Animals consuming a diet rich in DHA and EPA exhibited a significant upregulation in FABP5 mRNA levels at 7 dpi. Immunofluorescence showed low basal FABP5 immunoreactivity in spinal cord ventral gray matter NeuN+ neurons of sham-operated rats. SCI resulted in a robust induction of FABP5 in glial (GFAP+, APC+, and NG2+) and precursor cells (DCX+, nestin+). We found that continuous intrathecal administration of FABP5 silencing with small interfering RNA (2 μg) impaired spontaneous open-field locomotion post-SCI. Further, FABP5 siRNA administration hindered the beneficial effects of DHA to ameliorate functional recovery at 7 dpi. Altogether, our findings suggest that FABP5 may be an important player in the promotion of cellular uptake, transport, and/or metabolism of DHA post-SCI. Given the beneficial roles of n-3 PUFAs in ameliorating functional recovery, we propose that FABP5 is an important contributor to basic repair mechanisms in the injured spinal cord.
Get full access to this article
View all access options for this article.
References
1.
HulseboschC.E. (2002). Recent advances in pathophysiology and treatment of spinal cord injury. Adv. Physiol. Educ., 26, 238–255.
2.
HaggT., and OudegaM. (2006). Degenerative and spontaneous regenerative processes after spinal cord injury. J. Neurotrauma, 23, 264–280.
3.
YipP.K., and MalaspinaA. (2012). Spinal cord trauma and the molecular point of no return. Mol. Neurodegener., 7, 6.
4.
FigueroaJ.D., and De LeonM. (2014). Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury. Mol. Neurobiol., 50, 197–213.
5.
AndersonD.K., and HallE.D. (1993). Pathophysiology of spinal cord trauma. Ann. Emerg. Med., 22, 987–992.
6.
FadenA.I., ChanP.H., and LongarS. (1987). Alterations in lipid metabolism, Na+,K+-ATPase activity, and tissue water content of spinal cord following experimental traumatic injury. J. Neurochem., 48, 1809–1816.
7.
FujiedaY., UenoS., OginoR., KurodaM., JönssonT.J., GuoL., BambaT., and FukusakiE. (2012). Metabolite profiles correlate closely with neurobehavioral function in experimental spinal cord injury in rats. PLoS ONE, 7, e43152.
8.
FigueroaJ.D., CorderoK., llánM.S., and De LeonM. (2013). Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury. J. Neurotrauma, 30, 853–868.
9.
HuangW.L., KingV.R., CurranO.E., DyallS.C., WardR.E., LalN., PriestleyJ.V., and Michael-TitusA.T. (2007). A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain, 130, 3004–3019.
10.
KingV.R., HuangW.L., DyallS.C., CurranO.E., PriestleyJ.V., and Michael-TitusA.T. (2006). Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci., 26, 4672–4680.
11.
Lang-LazdunskiL., BlondeauN., JarretouG., LazdunskiM., and HeurteauxC. (2003). Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg., 38, 564–575.
12.
WardR.E., HuangW., CurranO.E., PriestleyJ.V., and Michael-TitusA.T. (2010). Docosahexaenoic acid prevents white matter damage after spinal cord injury. J. Neurotrauma, 27, 1769–1780.
13.
FigueroaJ.D., CorderoK., BaldeosinghK., TorradoA.I., WalkerR.L., MirandaJ.D., and LeonM.D. (2012). Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. J. Neurotrauma, 29, 551–566.
14.
MurphyE.J., BehrmannD., BatesC.M., and HorrocksL.A. (1994). Lipid alterations following impact spinal cord injury in the rat. Mol. Chem. Neuropathol., 23, 13–26.
15.
FigueroaJ.D., CorderoK., Serrano-IllanM., AlmeydaA., BaldeosinghK., AlmaguelF.G., and De LeonM. (2013). Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury. Neuroscience, 255, 1–18.
16.
LimS.-N., HuangW., HallJ.C.E., Michael-TitusA.T., and PriestleyJ.V. (2013). Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp. Neurol., 239, 13–27.
17.
MatsumataM., SakayoriN., MaekawaM., OwadaY., YoshikawaT., and OsumiN. (2012). The effects of Fabp7 and Fabp5 on postnatal hippocampal neurogenesis in the mouse. Stem Cells, 30, 1532–1543.
18.
ShiodaN., YamamotoY., WatanabeM., BinasB., OwadaY., and FukunagaK. (2010). Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain. J. Neurosci., 30, 3146–3155.
19.
YuS., LeviL., CasadesusG., KunosG., and NoyN. (2014). Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain. J. Biol. Chem., 289, 12748–12758.
20.
GerstnerJ.R., VanderheydenW.M., LaVauteT., WestmarkC.J., RouhanaL., PackA.I., WickensM., and LandryC.F. (2012). Time of day regulates subcellular trafficking, tripartite synaptic localization, and polyadenylation of the astrocytic Fabp7 mRNA. J. Neurosci., 32, 1383–1394.
21.
HanhoffT., LückeC., and SpenerF. (2002). Insights into binding of fatty acids by fatty acid binding proteins. Mol. Cell. Biochem., 239, 45–54.
22.
XuL.Z., SánchezR., SaliA., and HeintzN. (1996). Ligand specificity of brain lipid-binding protein. J. Biol. Chem., 271, 24711–24719.
23.
BalendiranG.K., SchnütgenF., ScapinG., BörchersT., XhongN., LimK., GodboutR., SpenerF., and SacchettiniJ.C. (2000). Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J. Biol. Chem., 275, 27045–27054.
24.
KaneC.D., CoeN.R., VanlandinghamB., KriegP., and BernlohrD.A. (1996). Expression, purification, and ligand-binding analysis of recombinant keratinocyte lipid-binding protein (MAL-1), an intracellular lipid-binding found overexpressed in neoplastic skin cells. Biochemistry, 35, 2894–2900.
25.
LiuJ.-W., AlmaguelF.G., BuL., De LeonD.D., and De LeonM. (2008). Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids. J. Neurochem., 106, 2015–2029.
26.
LiuY., MolinaC.A., WelcherA.A., LongoL.D., and De LeonM. (1997). Expression of DA11, a neuronal-injury-induced fatty acid binding protein, coincides with axon growth and neuronal differentiation during central nervous system development. J. Neurosci. Res., 48, 551–562.
27.
LiuY., LongoL.D., and De LeonM. (2000). In situ and immunocytochemical localization of E-FABP mRNA and protein during neuronal migration and differentiation in the rat brain. Brian Res. 852, 16–27.
28.
AllenG.W., LiuJ., KirbyM.A., and De LeonM. (2001). Induction and axonal localization of epithelial/epidermal fatty acid-binding protein in retinal ganglion cells are associated with axon development and regeneration. J. Neurosci. Res., 66, 396–405.
29.
BonevaN.B., MoriY., KaplamadzhievD.B., KikuchiH., ZhuH., KikuchiM., TonchevA.B., and YamashimaT. (2010). Differential expression of FABP 3, 5, 7 in infantile and adult monkey cerebellum. Neurosci. Res., 68, 94–102.
30.
OwadaY., YoshimotoT., and KondoH. (1996). Increased expression of the mRNA for brain- and skin-type but not heart-type fatty acid binding proteins following kainic acid systemic administration in the hippocampal glia of adult rats. Brain Res. Mol. Brain Res., 42, 156–160.
31.
De LeonM., WelcherA.A., NahinR.H., LiuY., RudaM.A., ShooterE.M., and MolinaC.A. (1996). Fatty acid binding protein is induced in neurons of the dorsal root ganglia after peripheral nerve injury. J. Neurosci. Res., 44, 283–292.
32.
MaD., ZhangM., MoriY., YaoC., LarsenC.P., YamashimaT., and ZhouL. (2010). Cellular localization of epidermal-type and brain-type fatty acid-binding proteins in adult hippocampus and their response to cerebral ischemia. Hippocampus, 20, 811–819.
33.
AllenG.W., LiuJ.W., and De LeónM. (2000). Depletion of a fatty acid-binding protein impairs neurite outgrowth in PC12 cells. Brain Res. Mol. Brain Res., 76, 315–324.
34.
LiuJ.-W., MonteroM., BuL., and De LeonM. (2015). Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injury. J. Neurochem., 132, 85–98.
35.
GrunerJ.A. (1992). A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma, 9, 123–126; discussion, 126–128.
36.
KumarK.K., GoodwinC.R., UhouseM.A., BornhorstJ., SchwerdtleT., AschnerM., McLeanJ.A., and BowmanA.B. (2015). Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics, 7, 363–370.
37.
McFaddenJ.W., AjaS., LiQ., BandaruV.V.R., KimE.-K., HaugheyN.J., KuhajdaF.P., and RonnettG.V. (2014). Increasing fatty acid oxidation remodels the hypothalamic neurometabolome to mitigate stress and inflammation. PLoS ONE, 9, e115642.
38.
BlankmanJ.L., LongJ.Z., TraugerS.A., SiuzdakG., and CravattB.F. (2013). ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc. Natl. Acad. Sci. U. S. A., 110, 1500–1505.
39.
BlascoH., CorciaP., PradatP.-F., BoccaC., GordonP.H., Veyrat-DurebexC., MavelS., Nadal-DesbaratsL., MoreauC., DevosD., AndresC.R., and EmondP. (2013). Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J. Proteome Res., 12, 3746–3754.
40.
DehavenC.D., EvansA.M., DaiH., and LawtonK.A. (2010). Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J. Cheminform., 2, 9.
41.
FigueroaJ.D., BentonR.L., VelazquezI., TorradoA.I., OrtizC.M., HernandezC.M., DiazJ.J., MagnusonD.S., WhittemoreS.R., and MirandaJ.D. (2006). Inhibition of EphA7 up‐regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery. J. Neurosci. Res., 84, 1438–1451.
42.
Cruz-OrengoL., FigueroaJ.D., TorradoA., PuigA., WhittemoreS.R., and MirandaJ.D. (2007). Reduction of EphA4 receptor expression after spinal cord injury does not induce axonal regeneration or return of tcMMEP response. Neurosci. Lett., 418, 49–54.
43.
BassoD.M., BeattieM.S., and BresnahanJ.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma, 12, 1–21.
44.
BelayevL., MarcheselliV.L., KhoutorovaL., Rodriguez de TurcoE.B., BustoR., GinsbergM.D., and BazanN.G. (2005). Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke, 36, 118–123.
45.
LuoM.-C., ZhangD.-Q., MaS.-W., HuangY.-Y., ShusterS.J., PorrecaF., and LaiJ. (2005). An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol. Pain, 1, 29–29.
46.
Cruz-OrengoL., FigueroaJ.D., VelazquezI., TorradoA., OrtízC., HernándezC., PuigA., SegarraA.C., WhittemoreS.R., and MirandaJ.D. (2006). Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain. Exp. Neurol., 202, 421–433.
47.
XiaJ., SinelnikovI.V., HanB., and WishartD.S. (2015). MetaboAnalyst 3.0–making metabolomics more meaningful. Nucleic Acids Res. 43, W251–W257.
48.
BailesJ.E., and MillsJ.D. (2010). Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma, 27, 1617–1624.
49.
WuA., YingZ., and Gómez-PinillaF. (2004). Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma, 21, 1457–1467.
50.
SatkunendrarajahK., and FehlingsM.G. (2013). Do omega-3 polyunsaturated fatty acids ameliorate spinal cord injury?: Commentary on: Lim et al., Improved outcome after spinal cord compression injury in mice treated with docosahexaeonic acid. Exp. Neurol. Jan; 239:13–27. Exp. Neurol., 239, 104–110.
51.
HaunerlandN.H., and SpenerF. (2004). Fatty acid-binding proteins—insights from genetic manipulations. Prog. Lipid Res., 43, 328–349.
52.
ShimamotoC., OhnishiT., MaekawaM., WatanabeA., OhbaH., AraiR., IwayamaY., HisanoY., ToyotaT., ToyoshimaM., SuzukiK., ShirayamaY., NakamuraK., MoriN., OwadaY., KobayashiT., and YoshikawaT. (2014). Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies. Hum. Mol. Genet., 23, 6495–6511.
53.
SchnellA., ChappuisS., SchmutzI., BraiE., RippergerJ.A., SchaadO., WelzlH., DescombesP., AlberiL., and AlbrechtU. (2014). The nuclear receptor REV-ERBα regulates Fabp7 and modulates adult hippocampal neurogenesis. PLoS ONE, 9, e99883.
RaoE., SinghP., LiY., ZhangY., ChiY.-I., SuttlesJ., and LiB. (2015). Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis. BMC Immunol., 16, 28.
56.
MurphyE.J., OwadaY., KitanakaN., KondoH., and GlatzJ.F.C. (2005). Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry, 44, 6350–6360.
57.
MurphyE.J., Barceló-CoblijnG., BinasB., and GlatzJ.F.C. (2004). Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. J. Biol. Chem., 279, 34481–34488.
58.
DesaiA., KevalaK., and KimH.-Y. (2014). Depletion of brain docosahexaenoic acid impairs recovery from traumatic brain injury. PLoS ONE, 9, e86472.
59.
OdaniS., NakamuraJ., SatoT., and FujiiH. (2001). Identification of a rat 30-kDa protein recognized by the antibodies to a recombinant rat cutaneous fatty acid-binding protein as a 14-3-3 protein. J. Biochem., 129, 213–219.
60.
Bennaars-EidenA., HigginsL., HertzelA.V., KapphahnR.J., FerringtonD.A., and BernlohrD.A. (2002). Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J. Biol. Chem., 277, 50693–50702.
61.
PelsersM.M., and GlatzJ.F.C. (2005). Detection of brain injury by fatty acid-binding proteins. Clin. Chem. Lab. Med., 43, 802–809.
62.
Saino-SaitoS., NouraniR.M., IwasaH., KondoH., and OwadaY. (2009). Discrete localization of various fatty-acid-binding proteins in various cell populations of mouse retina. Cell Tissue Res. 338, 191–201.
63.
BonevaN.B., KaplamadzhievD.B., SaharaS., KikuchiH., PykoI.V., KikuchiM., TonchevA.B., and YamashimaT. (2011). Expression of fatty acid-binding proteins in adult hippocampal neurogenic niche of postischemic monkeys. Hippocampus, 21, 162–171.
64.
OwadaY. (2008). Fatty acid binding protein: localization and functional significance in the brain. Tohoku J. Exp. Med., 214, 213–220.
65.
WhiteR.E., McTigueD.M., and JakemanL.B. (2010). Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice. J. Comp. Neurol., 518, 1370–1390.
66.
SharifiK., MorihiroY., MaekawaM., YasumotoY., HoshiH., AdachiY., SawadaT., TokudaN., KondoH., YoshikawaT., SuzukiM., and OwadaY. (2011). FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation. Histochem. Cell Biol., 136, 501–513.
67.
MooreS.A. (2001). Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J. Mol. Neurosci., 16, 195–200; discussion, 215–221.
68.
WilliardD.E., HarmonS.D., KaduceT.L., PreussM., MooreS.A., RobbinsM.E., and SpectorA.A. (2001). Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J. Lipid Res., 42, 1368–1376.
69.
SellersD.L., MarisD.O., and HornerP.J. (2009). Postinjury niches induce temporal shifts in progenitor fates to direct lesion repair after spinal cord injury. J. Neurosci., 29, 6722–6733.
70.
CalderonF., and KimH.-Y. (2004). Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem., 90, 979–988.
71.
RobsonL.G., DyallS., SidloffD., and Michael-TitusA.T. (2010). Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol. Aging, 31, 678–687.
72.
NakatoM., MatsuoM., KonoN., AritaM., AraiH., OgawaJ., KiokaN., and UedaK. (2015). Neurite outgrowth stimulation by n3 and n6 polyunsaturated fatty acids of phospholipids in apolipoprotein E containing lipoproteins secreted from glial cells. J. Lipid Res., 56, 1880–1890.
73.
AuestadN., and InnisS.M. (2000). Dietary n-3 fatty acid restriction during gestation in rats: neuronal cell body and growth-cone fatty acids. Am. J. Clin. Nutr., 71, 1 Suppl., 312S–314S.
74.
BermanD.R., LiuY.Q., BarksJ., and MozurkewichE. (2010). Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation. Am. J. Obstet. Gynecol., 202, 469.e1–6.
75.
BermanD.R., MozurkewichE., LiuY., and BarksJ. (2009). Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am. J. Obstet. Gynecol., 200, 305.e1–6.
